Valuation Geron Corporation

Stocks

Market Closed - Nasdaq 00:00:00 03/11/2026 +03			5-day change	1st Jan Change
0.9291 ^USD	+3.88%		-19.21%	-29.61%

10-28	Geron's Core Rytelo Business Remains on Track Despite Trial Halt, Wedbush Says	MT
10-28	Geron Corporation Provides Update on Phase 3 IMpactMF Clinical Trial of Imetelstat in Relapsed/Refractory Myelofibrosis	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	392.8	922.6	1,146	2,140	842.6	596.9	-	-
Change	-	134.89%	24.2%	86.75%	-60.62%	-29.16%	-	-
Enterprise Value (EV)	392.8	922.6	1,162	2,140	882.7	596.9	596.9	596.9
Change	-	134.89%	25.92%	84.2%	-58.75%	-32.38%	0%	0%
P/E	-3.49x	-6.54x	-6.59x	-13.1x	-10.2x	-21.1x	14.1x	4.13x
PBR	-	-	-	-	-	-	-	-
PEG	-	-1.14x	0.5x	0.8x	0.2x	0.3x	-0x	0x
Capitalization / Revenue	282x	1,548x	4,835x	27.8x	4.58x	2.54x	1.75x	1.14x
EV / Revenue	0x	0x	0x	0x	0x	2.54x	1.75x	1.14x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	-0x	-0x	-0x	-64.8x	10.7x	4.76x
EV / FCF	-0x	-	-	-0x	0x	37.3x	7.46x	4.56x
FCF Yield	-29.6%	-	-	-15.2%	25.9%	2.68%	13.4%	21.9%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.35	-0.37	-0.32	-0.27	-0.13	-0.044	0.066	0.225
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1.393	0.596	0.237	76.99	183.9	235.4	341	525.1
EBITDA	-	-	-193.5	-	-68.11	-	-	-
EBIT ¹	-114	-138.6	-193.9	-173.7	-53.84	-9.213	56.02	125.3
Net income ¹	-116.1	-141.9	-184.1	-174.6	-85.78	-25.41	37.75	93.74
Net Debt	-	-	15.88	-	40.11	-	-	-
Reference price ²	1.2200	2.4200	2.1100	3.5400	1.3200	0.9291	0.9291	0.9291
Nbr of stocks (in thousands)	321,949	381,235	543,064	604,501	638,355	642,473	-	-
Announcement Date	3/10/22 A	3/16/23 A	2/28/24 A	2/26/25 A	2/25/26 A	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GERON CORPORATION	-20.33x	-	-	-	597M
WUXI APPTEC CO., LTD.	16.87x	6.34x	12.15x	1.77%	62.23B
ARGENX SE	30.14x	8.25x	27.02x	0.04%	54.92B
LONZA GROUP AG	37.48x	6.65x	19.86x	0.86%	55.26B
IQVIA HOLDINGS INC.	34.85x	3.31x	14.29x	-.--%	42.59B
BEONE MEDICINES AG	48.85x	5.63x	30.81x	-.--%	41.08B
REVOLUTION MEDICINES, INC.	-19.86x	192.36x	-21.16x	-.--%	40.33B
GENMAB A/S	47.33x	8.41x	28.18x	-.--%	33.12B
CELLTRION, INC.	32x	8.13x	21.15x	0.41%	32.61B
INSMED INCORPORATED	-70.14x	13.02x	-68.47x	-.--%	23.98B
Average	13.72x	28.01x	7.09x	0.34%	38.67B
Weighted average by Cap.	21.68x	26.42x	11.24x	0.45%